These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 773351)

  • 41. [Indices of the state of the pituitary-adrenal system in hereditary myopathies].
    Temin PA; Gerasimova OI; Savost'ianova NA; Medvedev MI; Faustov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):342-6. PubMed ID: 6266180
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum pyruvate kinase in muscle disease and carrier states.
    Alberts MC; Samaha FJ
    Neurology; 1974 May; 24(5):462-4. PubMed ID: 4857105
    [No Abstract]   [Full Text] [Related]  

  • 43. Slow motor nerve conduction in myotonic dystrophy.
    Roohi F; List T; Lovelace RE
    Electromyogr Clin Neurophysiol; 1981; 21(2-3):97-105. PubMed ID: 7262015
    [No Abstract]   [Full Text] [Related]  

  • 44. Significance of creatine phosphokinase isoenzymes in Duchenne dystrophy.
    Silverman LM; Mendell JR; Sahenk Z; Fontana MB
    Neurology; 1976 Jun; 26(6 PT 1):561-4. PubMed ID: 945499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle creatine phosphokinase in primary myopathies.
    Vester JW; Sabeh G; Newton RH; Finkelhor HB; Fetterman GH; Danowski TS
    Proc Soc Exp Biol Med; 1968 May; 128(1):5-8. PubMed ID: 5656716
    [No Abstract]   [Full Text] [Related]  

  • 46. Muscular dystrophy: evidence for a neural factor.
    Mc Comas AJ; Sica RE; Currie S
    Nature; 1970 Jun; 226(5252):1263-4. PubMed ID: 5422605
    [No Abstract]   [Full Text] [Related]  

  • 47. Terminal innervation ratio in neuromuscular disease. II. Disorders of lower motor neuron, peripheral nerve, and muscle.
    Coërs C; Telerman-Toppet N; Gerard JM
    Arch Neurol; 1973 Oct; 29(4):215-22. PubMed ID: 4353847
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmocologic therapy of dystrophy in man and animals.
    Munsat TL
    Ann N Y Acad Sci; 1979; 317():400-8. PubMed ID: 289320
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased plasma enzyme concentrations in rats with functional ischaemia of muscle provide a possible model of Duchenne muscular dystrophy.
    Mendell JR; Engel WK; Derrer EC
    Nature; 1972 Oct; 239(5374):522-4. PubMed ID: 4563024
    [No Abstract]   [Full Text] [Related]  

  • 50. [Systolic time intervals of the left ventricle in neuromuscular diseases].
    Pust B; Rakovec P
    Z Kardiol; 1976 Aug; 65(8):708-12. PubMed ID: 969822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sympathetic mediator theory of the pathogenesis of progressive muscular dystrophies (a review)].
    Badalian LO; Temin PA; Dzhabarov BD; Il'in IL; Kovaleva MIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1722-6. PubMed ID: 6119861
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intracellular localization of ATP; creatine phosphotransferase (creatine kinase) in skeletal muscles in experimental dystrophy].
    Grigor'eva VA; Pisak'ov VB
    Ukr Biokhim Zh; 1971; 43(4):453-8. PubMed ID: 5154537
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy.
    Takahashi K; Shutta K; Matsuo B; Takai T; Takao H; Imura H
    Clin Chim Acta; 1977 Mar; 75(3):435-42. PubMed ID: 852132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letter: Myopathies: the neurogenic hypothesis.
    Ballantyne JP; Hansen S
    Lancet; 1974 Sep; 2(7880):588-9. PubMed ID: 4140294
    [No Abstract]   [Full Text] [Related]  

  • 55. Purine metabolism in Duchenne muscular dystrophy.
    de Bruyn CH; Kulakowski S; van Bennekom CA; Renoirte P; Müller MM
    Adv Exp Med Biol; 1980; 122A():177-82. PubMed ID: 7424633
    [No Abstract]   [Full Text] [Related]  

  • 56. Early diagnosis of muscular dystrophy.
    Dubowitz V
    Practitioner; 1976 Apr; 216(1294):389-93. PubMed ID: 1273025
    [No Abstract]   [Full Text] [Related]  

  • 57. Computer method for the analysis of evoked motor unit potentials. 2. Duchenne, limb-girdle, facioscapulohumeral and myotonic muscular dystrophies.
    Ballantyne JP; Hansen S
    J Neurol Neurosurg Psychiatry; 1975 May; 38(5):417-28. PubMed ID: 1151411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Muscular dystrophy: a working hypothesis].
    Filippini C; Millefiorini M
    Riv Neurol; 1982; 52(2):117-32. PubMed ID: 7100782
    [No Abstract]   [Full Text] [Related]  

  • 59. An electrophysiological investigation of limb-girdle and facioscapulohumeral dystrophy.
    Sica RE; McComas AJ
    J Neurol Neurosurg Psychiatry; 1971 Aug; 34(4):469-74. PubMed ID: 5096560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of pulmonary function in neuromuscular disease.
    Griggs RC; Donohoe KM; Utell MJ; Goldblatt D; Moxley RT
    Arch Neurol; 1981 Jan; 38(1):9-12. PubMed ID: 7458733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.